Publication:
Medical costs of asbestos-related diseases in Spain between 2004 and 2011

Loading...
Thumbnail Image
Full text at PDC
Publication Date
2017
Authors
García Gómez, Montserrat
Castañeda lópez, Rosario
Menéndez Navarro, Alfredo
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
National Institute of Industrial Health
Citations
Google Scholar
Research Projects
Organizational Units
Journal Issue
Abstract
The objective of this article was to estimate the medical costs derived from malignant ARD treatment in the Spanish National Health System (NHS) between 2004 and 2011. Estimation of direct healthcare costs was based on national primary data on the cost of specialized care for inpatients and outpatients treated at NHS hospitals and on national and regional secondary data on costs of primary healthcare and pharmaceutical prescriptions. A prevalence approach was used to estimate the overall burden of ARDs. Direct medical costs of 37,557 ARDs attended in Spanish NHS facilities in 2004 – 2011 were estimated at 464 million euros; specialist care accounted for 50.9% of total costs, primary healthcare 10.15%, and drug prescription 38.9%. The cost was 27.8-fold higher in males than in females. Bronchopulmonary cancers represented the greatest healthcare cost, 281 million euros. The cost of delivering healthcare to ARDs victims in Spain has a negative economic impact on the NHS due to the gross under-recognition of occupational victims under the Spanish National Insurance System.
Description
Unesco subjects
Keywords
Citation
Collections